COMMUNIQUÉS West-GlobeNewswire

Healis Therapeutics announces collaboration with Massachusetts General Hospital (MGH) and affiliates of Harvard Medical School to advance clinical-stage neuroscience research
26/03/2024
NEWPORT BEACH, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Healis Therapeutics is pleased to announce that it has entered a clinical collaboration with Massachusetts General Hospital (MGH), a founding member of the Mass [...]
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
26/03/2024
NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the [...]
GTG Global Collaborations and Innovation Update
26/03/2024
MELBOURNE, Australia, March 26, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is [...]
Apollomics to Announce Full Year 2023 Financial Results and Host Conference Call on March 28, 2024
26/03/2024
FOSTER CITY, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers, today [...]
Opus Genetics Announces Completion of Dosing in First Cohort of Phase 1/2 Trial of Gene Therapy OPGx-LCA5 in Patients with Rare Inherited Retinal Disease LCA5
26/03/2024
OPGx-LCA5 will advance to the next highest dose in mid-2024 based on positive safety and efficacy data OPGx-LCA5 is well-tolerated and demonstrated clear signs of biological activity RESEARCH TRIANGLE PARK, N.C., March [...]
American Oncology Network Expands Footprint in Texas with the Addition of Woodlands Cancer Institute in Houston
26/03/2024
Woodlands Cancer Institute opens three clinic locations that provide medical oncology, radiation oncology and hematology care to its patients. WOODLANDS, Texas, March 26, 2024 (GLOBE NEWSWIRE) -- American Oncology [...]
HealthLynked Announces Exciting New Update with HealthLynked 3.2.0 - Transforming Patient-Care Through Innovation
26/03/2024
NAPLES, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- via IBN – HealthLynked Corp. (OTCQB: HLYK), a pioneering healthcare network focused on enhancing the efficiency and quality of patient care, is thrilled to announce the [...]
Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
26/03/2024
First-in-class macrocyclic ATR inhibitor, ATRN-119, on track to complete dose escalation and potentially generate human efficacy data in H2 2024 U.S. FDA cleared IND for APR-1051, a highly selective and potentially best [...]
Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response (PPR) Achieving 100% Response in Treated Patients
26/03/2024
In the 45 mg cohort, 100% of patients achieved a complete response In the 15 mg cohort, 80% of patients achieved a complete response and 20% achieved a partial response Safety was consistent with prior dose escalation [...]
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
26/03/2024
Data readout from Phase 3 clinical trial in the People's Republic of China ( “ PRC ”) evaluating F351 for the treatment of CHB-associated liver fibrosis expected by early 2025 U.S. Phase 2a clinical trial evaluating [...]
Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team
26/03/2024
STEVENAGE, United Kingdom, March 26, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced therapies to tackle major [...]
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
26/03/2024
First in human phase I clinical study using OMV as an adjuvant for intranasal vaccination Avacc 10 ® intranasal booster vaccine induces a mucosal response and no adverse events Data will be presented at the World [...]
Annual General Meeting 2024: Tecan proposes election of an additional member of the Board of Directors and various amendments to the Articles of Incorporation
26/03/2024
Annual General Meeting 2024: Tecan proposes election of an additional member of the Board of Directors and various amendments to the Articles of Incorporation Monica Manotas proposed as a new member of the Board of [...]
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
26/03/2024
PRESS RELEASE REGULATED INFORMATION 26 March 2024, 07:00 a.m. CET Ghent, Belgium, 26 March 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of [...]
argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia
26/03/2024
VYVGART ® now approved in Japan for both generalized myasthenia gravis and primary immune thrombocytopenia (ITP) Regulatory decision in Japan represents first global approval for VYVGART in ITP March 26, 2024 7:00 AM [...]
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
26/03/2024
Saint-Herblain (France), March 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the initiation of a Phase 1 clinical trial to investigate the the safety and [...]
Valneva lance un essai de Phase 1 sur son candidat vaccin de deuxième génération contre le virus Zika
26/03/2024
Saint-Herblain (France), le 26 mars 2024 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui l’initiation d’un essai de Phase 1 pour évaluer l’innocuité et l’ [...]
CARBIOS joins Paris Good Fashion to accelerate textile circularity and contribute to more sustainable fashion
26/03/2024
CARBIOS joins Paris Good Fashion to accelerate textile circularity and contribute to more sustainable fashion Clermont-Ferrand, France, Tuesday 26 March 2024 (06.45am CET) CARBIOS (Euronext Growth Paris: ALCRB), a [...]
CARBIOS rejoint Paris Good Fashion pour accélérer la circularité des textiles et contribuer à une mode plus durable
26/03/2024
CARBIOS rejoint Paris Good Fashion pour accélérer la circularité des textiles et contribuer à une mode plus durable Clermont-Ferrand (France), le mardi 26 mars 2024 (06h45 CET). CARBIOS , (Euronext Growth Paris : ALCRB [...]

Pages